132 related articles for article (PubMed ID: 1777219)
21. In lymph node-negative invasive breast carcinomas, specific chromosomal aberrations are strongly associated with high mitotic activity and predict outcome more accurately than grade, tumour diameter, and oestrogen receptor.
Janssen EA; Baak JP; Guervós MA; van Diest PJ; Jiwa M; Hermsen MA
J Pathol; 2003 Dec; 201(4):555-61. PubMed ID: 14648658
[TBL] [Abstract][Full Text] [Related]
22. Survival of women with node negative breast cancer in the Auckland region.
Lethaby AE; Mason BH; Harvey VJ; Holdaway IM
N Z Med J; 1996 Sep; 109(1029):330-3. PubMed ID: 8862351
[TBL] [Abstract][Full Text] [Related]
23. The significance of nuclear morphometric variables as prognostic predictors in breast cancer.
Aaltomaa S; Lipponen P; Eskelinen M; Kosma VM; Marin S; Alhava E; Syrjänen K
Anticancer Res; 1991; 11(4):1663-9. PubMed ID: 1746922
[TBL] [Abstract][Full Text] [Related]
24. Progesterone and estrogen receptors as prognostic variables in breast cancer.
Mason BH; Holdaway IM; Mullins PR; Yee LH; Kay RG
Cancer Res; 1983 Jun; 43(6):2985-90. PubMed ID: 6850609
[TBL] [Abstract][Full Text] [Related]
25. [Epidermal growth factor receptor in human breast cancer: correlation with steroid receptors, tumor stage, grading and menopausal status].
Speiser P; Sliutz G; Zeillinger R; Czerwenka K; Jakesz R; Knogler W; Kury F; Reiner A; Sevelda P; Schneeberger C
Geburtshilfe Frauenheilkd; 1992 Jun; 52(6):355-9. PubMed ID: 1634099
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of steroid receptors after long-term follow-up of 2257 operable breast cancers.
Pichon MF; Broet P; Magdelenat H; Delarue JC; Spyratos F; Basuyau JP; Saez S; Rallet A; Courriere P; Millon R; Asselain B
Br J Cancer; 1996 Jun; 73(12):1545-51. PubMed ID: 8664127
[TBL] [Abstract][Full Text] [Related]
27. Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer.
Allegra JC; Lippman ME; Thompson EB; Simon R; Barlock A; Green L; Huff KK; Do HM; Aitken SC
Cancer Res; 1979 May; 39(5):1447-54. PubMed ID: 427788
[TBL] [Abstract][Full Text] [Related]
28. Immunofluorometrically determined p53 accumulation as a prognostic indicator in Italian breast cancer patients.
Levesque MA; Katsaros D; Yu H; Giai M; Genta F; Roagna R; Ponzone R; Massobrio M; Sismondi P; Diamandis EP
Int J Cancer; 1998 Apr; 79(2):147-52. PubMed ID: 9583729
[TBL] [Abstract][Full Text] [Related]
29. Biomarker expression and St Gallen molecular subtype classification in primary tumours, synchronous lymph node metastases and asynchronous relapses in primary breast cancer patients with 10 years' follow-up.
Falck AK; Bendahl PO; Chebil G; Olsson H; Fernö M; Rydén L
Breast Cancer Res Treat; 2013 Jul; 140(1):93-104. PubMed ID: 23807420
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of oestrogen and progestogen receptor activities in breast cancer.
Hawkins RA; White G; Bundred NJ; Dixon JM; Miller WR; Stewart HJ; Forrest AP
Br J Surg; 1987 Nov; 74(11):1009-13. PubMed ID: 3690224
[TBL] [Abstract][Full Text] [Related]
31. Multivariate analysis of DNA ploidy, p53, c-erbB-2 proteins, EGFR, and steroid hormone receptors for prediction of poor short term prognosis in breast cancer.
Eissa S; Khalifa A; el-Gharib A; Salah N; Mohamed MK
Anticancer Res; 1997; 17(2B):1417-23. PubMed ID: 9137508
[TBL] [Abstract][Full Text] [Related]
32. Progesterone receptor quantification as a strong prognostic determinant in postmenopausal breast cancer women under tamoxifen therapy.
Lamy PJ; Pujol P; Thezenas S; Kramar A; Rouanet P; Guilleux F; Grenier J
Breast Cancer Res Treat; 2002 Nov; 76(1):65-71. PubMed ID: 12408377
[TBL] [Abstract][Full Text] [Related]
33. S-phase fraction and nuclear size in long term prognosis of patients with breast cancer.
Meyer JS; Province MA
Cancer; 1994 Oct; 74(8):2287-99. PubMed ID: 7922981
[TBL] [Abstract][Full Text] [Related]
34. Association between HER-2/neu and the progesterone receptor in oestrogen-dependent breast cancer is age-related.
Huang HJ; Neven P; Drijkoningen M; Paridaens R; Wildiers H; Van Limbergen E; Berteloot P; Amant F; Christiaens MR; Vergote I
Breast Cancer Res Treat; 2005 May; 91(1):81-7. PubMed ID: 15868434
[TBL] [Abstract][Full Text] [Related]
35. [Expression of oestrogen receptor-beta in invasive breast tumours].
Péter I; Számel I; Péley G
Magy Onkol; 2004; 48(1):63-9. PubMed ID: 15105898
[TBL] [Abstract][Full Text] [Related]
36. [Long-term prognostic role of steroid receptors in cancer of the breast].
Broët P; Pichon MF; Magdelenat H; Delarue JC; Spyratos F; Basuyau JP; Saez S; Rallet A; Courrière P; Millon R; Asselain B
Bull Cancer; 1998 Apr; 85(4):347-52. PubMed ID: 9752299
[TBL] [Abstract][Full Text] [Related]
37. Progesterone and estrogen receptors in meningiomas: prognostic considerations.
Hsu DW; Efird JT; Hedley-Whyte ET
J Neurosurg; 1997 Jan; 86(1):113-20. PubMed ID: 8988089
[TBL] [Abstract][Full Text] [Related]
38. Nuclear areas in breast cancer: relationship with estrogen and progesterone receptor expression.
Maiorana A; Cavallari V; Bagni A; Ussia F; Maiorana MC; Fano RA
Anal Cell Pathol; 1996 Aug; 11(3):199-209. PubMed ID: 8888955
[TBL] [Abstract][Full Text] [Related]
39. Oestrogen and progesterone receptors in Nigerian breast cancer: relationship to tumour histopathology and survival of patients.
Ikpatt OF; Ndoma-Egba R
Cent Afr J Med; 2003; 49(11-12):122-6. PubMed ID: 15301464
[TBL] [Abstract][Full Text] [Related]
40. [Breast cancer: prognostic value of flow cytometry and hormone receptors. Apropos of a Lebanese series of patients].
Aftimos G; Trak-Smayra V; Moacdieh-Rehayel L
J Med Liban; 2000; 48(1):8-17. PubMed ID: 10881437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]